医学出版社であるメディカルレビュー社から、医療関係者の皆様に医学論文概要の読み上げ音声を毎週火曜日にお届けします。 日頃忙しい皆様に「耳で読む」かたちで医学論文の音声を英語・日本語でお届けしていきます。 (読み上げ音声はAIを使用して作成しています。)
Quick Med Insights -耳で読む論文-
Claim This Podcastby 株式会社メディカルレビュー社
100 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇯🇵
Podcast Overview
医学出版社であるメディカルレビュー社から、医療関係者の皆様に医学論文概要の読み上げ音声を毎週火曜日にお届けします。 日頃忙しい皆様に「耳で読む」かたちで医学論文の音声を英語・日本語でお届けしていきます。 (読み上げ音声はAIを使用して作成しています。)
Language
🇯🇵
Publishing Since
10/23/2024
Reach the team behind Quick Med Insights -耳で読む論文-
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
June 18, 2026
＜この研究が熱い！気になる論文紹介＞ 中等症〜重症乾癬を対象とした、世界初の経口IL-23受容体阻害薬「イコトロキンラ」の第Ⅲ相試験結果を読み解
<p>Gold LS, Armstrong AW, Bissonnette R, et al. Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials. Lancet. 2025;406:1363-74. </p><p>doi: 10.1016/S0140-6736(25)01576-4. </p>
December 23, 2025
レジリエンス訓練の有効性：医療職向けメンタルスキルトレーニングの臨床研究
AI commentator examines three medical papers on mental skills training for healthcare professionals, focusing on resilience, stress response, and self-efficacy in clinical settings.
December 12, 2025
片頭痛の新治療：CGRP関連薬の有効性・副作用・日常生活での使いこなし
This episode of Quick Med Insights analyzes recent medical papers on novel migraine treatments, specifically CGRP-related drugs, and their effectiveness, side effects, and practical use in daily life.
100 total episodes available
Deep-dive analytics for Quick Med Insights -耳で読む論文-
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Quick Med Insights -耳で読む論文-?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.